Author:
Feuring Martin,Lee Yih,Orlowski Laura H.,Michiels Nicole,De Smet Marina,Majumdar Anup K.,Petty Kevin J.,Goldberg Michael R.,Murphy M. Gail,Gottesdiener Keith M.,Hesney Michael,Brackett L. Ellen,Wehling Martin
Subject
Pharmacology (medical),Pharmacology
Reference19 articles.
1. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone;Campos;J Clin Oncol,2001
2. Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis;Cocquyt;Eur J Cancer,2001
3. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist;Navari;N Engl J Med,1999
4. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869: a randomized controlled trial;Belle;Cancer,2002
5. Metabolism of aprepitant, a substance P receptor antagonist, using in vitro systems from rat and human livers;Huskey;Drug Metab Dispos,2003
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献